发明名称 |
INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT OF SAME |
摘要 |
The present invention provides a compound represented by general formula (I) (in the formula: A is a benzene ring, pyridine ring, or the like; Y1 is an alkylene group having 1-6 carbon atoms, or the like; Y2 is a single bond or the like; Z is -C(=O)-NHSO2R6, an acidic 5-membered heterocycle group, or the like; R1 is a hydrogen atom or the like; R2 is a phenyl group, a 5-membered aromatic heterocycle group, or the like; R3 is a halogen atom, an alkoxy group having 1-6 carbon atoms, or the like; R4 is a hydrogen atom, a halogen atom, or the like; R5 is a hydrogen atom or the like; and R6 represents an alkyl group having 1-6 carbon atoms, or the like) having EP1 receptor antagonism, and a pharmacologically acceptable salt of same. Furthermore, the compound (I) can be used as a therapeutic drug or a preventative drug for various symptoms of LUTS, particularly OABs. |
申请公布号 |
WO2012102255(A1) |
申请公布日期 |
2012.08.02 |
申请号 |
WO2012JP51402 |
申请日期 |
2012.01.24 |
申请人 |
KISSEI PHARMACEUTICAL CO., LTD.;KYORIN PHARMACEUTICAL CO., LTD.;TATANI, KAZUYA;KONDO, ATSUSHI;KONDO, TATSUHIRO;KAWAMURA, NAOHIRO |
发明人 |
TATANI, KAZUYA;KONDO, ATSUSHI;KONDO, TATSUHIRO;KAWAMURA, NAOHIRO |
分类号 |
C07D209/18;A61K31/404;A61K31/41;A61K31/427;A61K31/4439;A61K31/444;A61K31/506;A61K45/00;A61P13/02;A61P13/10;A61P43/00;C07D401/06;C07D401/14;C07D403/10;C07D405/06;C07D405/14;C07D409/14;C07D413/14;C07D417/06;C07D419/14 |
主分类号 |
C07D209/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|